PCM
BPMC
Peregrine Capital Management’s Blueprint Medicines BPMC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-96,149
| Closed | -$8.51M | – | 333 |
|
|
2025
Q1 | $8.51M | Sell |
96,149
-2,663
| -3% | -$236K | 0.28% | 92 |
|
|
2024
Q4 | $8.62M | Buy |
98,812
+1,761
| +2% | +$154K | 0.26% | 104 |
|
|
2024
Q3 | $8.98M | Buy |
97,051
+17,491
| +22% | +$1.62M | 0.27% | 87 |
|
|
2024
Q2 | $8.57M | Sell |
79,560
-14,023
| -15% | -$1.51M | 0.25% | 108 |
|
|
2024
Q1 | $8.88M | Buy |
93,583
+1,810
| +2% | +$172K | 0.25% | 104 |
|
|
2023
Q4 | $8.47M | Sell |
91,773
-54,890
| -37% | -$5.06M | 0.25% | 119 |
|
|
2023
Q3 | $7.37M | Buy |
146,663
+3,074
| +2% | +$154K | 0.22% | 183 |
|
|
2023
Q2 | $9.07M | Sell |
143,589
-16,015
| -10% | -$1.01M | 0.25% | 153 |
|
|
2023
Q1 | $7.18M | Buy |
159,604
+31,362
| +24% | +$1.41M | 0.21% | 210 |
|
|
2022
Q4 | $5.62M | Buy |
128,242
+15,954
| +14% | +$699K | 0.18% | 225 |
|
|
2022
Q3 | $7.4M | Sell |
112,288
-20,333
| -15% | -$1.34M | 0.24% | 193 |
|
|
2022
Q2 | $6.7M | Buy |
132,621
+5,753
| +5% | +$291K | 0.2% | 222 |
|
|
2022
Q1 | $8.1M | Buy |
126,868
+3,199
| +3% | +$204K | 0.19% | 216 |
|
|
2021
Q4 | $13.2M | Buy |
123,669
+3,500
| +3% | +$375K | 0.27% | 124 |
|
|
2021
Q3 | $12.4M | Sell |
120,169
-39,414
| -25% | -$4.05M | 0.26% | 155 |
|
|
2021
Q2 | $14M | Buy |
159,583
+8,471
| +6% | +$745K | 0.25% | 182 |
|
|
2021
Q1 | $14.7M | Sell |
151,112
-21,086
| -12% | -$2.05M | 0.27% | 179 |
|
|
2020
Q4 | $19.3M | Sell |
172,198
-15,651
| -8% | -$1.76M | 0.37% | 90 |
|
|
2020
Q3 | $17.4M | Buy |
187,849
+17,742
| +10% | +$1.64M | 0.46% | 75 |
|
|
2020
Q2 | $13.3M | Sell |
170,107
-28,360
| -14% | -$2.21M | 0.38% | 107 |
|
|
2020
Q1 | $11.6M | Buy |
+198,467
| New | +$11.6M | 0.42% | 100 |
|